| 1Z3N | A: | HUMAN ALDOSE REDUCTASE IN COMPLEX WITH NADP+ AND THE INHIBITOR LIDORESTAT AT 1.04 ANGSTROM |
| 1Z89 | A: | HUMAN ALDOSE REDUCTASE COMPLEXED WITH NOVEL SULFONYL-PYRIDAZINONE INHIBITOR |
| 1Z8A | A: | HUMAN ALDOSE REDUCTASE COMPLEXED WITH NOVEL SULFONYL-PYRIDAZINONE INHIBITOR |
| 1ZSX | A: | CRYSTAL STRUCTURE OF HUMAN POTASSIUM CHANNEL KV BETA-SUBUNIT (KCNAB2) |
| 2BP1 | A:; B:; C:; D: | STRUCTURE OF THE AFLATOXIN ALDEHYDE REDUCTASE IN COMPLEX WITH NADPH |
| 2CLP | A:; B:; C:; D:; E:; F:; G:; H:; I:; J:; K: | CRYSTAL STRUCTURE OF HUMAN AFLATOXIN B1 ALDEHYDE REDUCTASE MEMBER 3 |
| 2DUX | A: | CRYSTAL STRUCTURE OF HUMAN ALDOSE REDUCTASE COMPLEXED WITH ZOPOLRESTAT AFTER 3 DAYS SOAKING (3DAYS_SOAKED_1) |
| 2DUZ | A: | HUMAN ALDOSE REDUCTASE COMPLEXED WITH INHIBITOR ZOPOLRESTAT AFTER 3 DAYS SOAKING (3DAYS_SOAKED_2) |
| 2DV0 | A: | HUMAN ALDOSE REDUCTASE COMPLEXED WITH ZOPOLRESTAT AFTER 6 DAYS SOAKING(6DAYS_SOAKED_2) |
| 2FVL | A:; B:; C: | CRYSTAL STRUCTURE OF HUMAN 3-ALPHA HYDROXYSTEROID/DIHYDRODIOL DEHYDROGENASE (AKR1C4) COMPLEXED WITH NADP+ |
| 2HV5 | A: | HUMAN ALDOSE REDUCTASE COMPLEXED WITH INHIBITOR ZOPOLRESTAT AFTER THREE DAYS SOAKING (3DAYS_SOAKED_3) |
| 2HVN | A: | HUMAN ALDOSE REDUCTASE-ZOPOLRESTAT COMPLEX OBTAINED BY COCRYSTALLISATION AFTER ONE DAY (1DAY_COCRYST) |
| 2HVO | A: | HUMAN ALDOSE REDUCTASE-ZOPOLRESTAT COMPLEX OBTAINED BY COCRYSTALLISATION (10DAYS_COCRYST) |
| 2I16 | A: | HUMAN ALDOSE REDUCTASE IN COMPLEX WITH NADP+ AND THE INHIBITOR IDD594 AT TEMPERATURE OF 15K |
| 2I17 | A: | HUMAN ALDOSE REDUCTASE IN COMPLEX WITH NADP+ AND THE INHIBITOR IDD594 AT TEMPERATURE OF 60K |
| 2IKG | A: | ALDOSE REDUCTASE COMPLEXED WITH NITROPHENYL-OXADIAZOL TYPE INHIBITOR AT 1.43 A |
| 2IKH | A: | HUMAN ALDOSE REDUCTASE COMPLEXED WITH NITROFURYL-OXADIAZOL INHIBITOR AT 1.55 A |
| 2IKI | A: | HUMAN ALDOSE REDUCTASE COMPLEXED WITH HALOGENATED IDD-TYPE INHIBITOR |
| 2IKJ | A: | HUMAN ALDOSE REDUCTASE COMPLEXED WITH NITRO-SUBSTITUTED IDD-TYPE INHIBITOR |
| 2J8T | A: | HUMAN ALDOSE REDUCTASE IN COMPLEX WITH NADP AND CITRATE AT 0.82 ANGSTROM |
| 2NVC | A: | HUMAN ALDOSE REDUCTASE COMPLEXED WITH NOVEL NAPHTHO[1,2-D]ISOTHIAZOLE ACETIC ACID DERIVATIVE (3) |
| 2NVD | A: | HUMAN ALDOSE REDUCTASE COMPLEXED WITH NOVEL NAPHTHO[1,2-D]ISOTHIAZOLE ACETIC ACID DERIVATIVE (2) |
| 2QXW | A: | PERDEUTERATED ALR2 IN COMPLEX WITH IDD594 |
| 2R24 | A: | HUMAN ALDOSE REDUCTASE STRUCTURE |
| 3BCJ | A: | CRYSTAL STRUCTURE OF ALDOSE REDUCTASE COMPLEXED WITH 2S4R (STEREOISOMER OF FIDARESTAT, 2S4S) AT 0.78 A |
| 3BUR | A:; B: | CRYSTAL STRUCTURE OF DELTA(4)-3-KETOSTEROID 5-BETA-REDUCTASE IN COMPLEX WITH NADP AND TESTOSTERONE. RESOLUTION: 1.62 A. |
| 3BUV | A:; B: | CRYSTAL STRUCTURE OF HUMAN DELTA(4)-3-KETOSTEROID 5-BETA-REDUCTASE IN COMPLEX WITH NADP AND HEPES. RESOLUTION: 1.35 A. |
| 3BV7 | A:; B: | CRYSTAL STRUCTURE OF DELTA(4)-3-KETOSTEROID 5-BETA-REDUCTASE IN COMPLEX WITH NADP AND GLYCEROL. RESOLUTION: 1.79 A. |
| 3C3U | A: | CRYSTAL STRUCTURE OF AKR1C1 IN COMPLEX WITH NADP AND 3,5-DICHLOROSALICYLIC ACID |
| 3CAQ | A:; B: | CRYSTAL STRUCTURE OF 5BETA-REDUCTASE (AKR1D1) IN COMPLEX WITH NADPH |
| 3CAS | A:; B: | CRYSTAL STRUCTURE OF 5BETA-REDUCTASE (AKR1D1) IN COMPLEX WITH NADP+ AND 4-ANDROSTENEDIONE |
| 3CAV | A:; B: | CRYSTAL STRUCTURE OF 5BETA-REDUCTASE (AKR1D1) IN COMPLEX WITH NADP+ AND 5BETA-PREGNAN-3,20-DIONE |
| 3CMF | A:; B: | CRYSTAL STRUCTURE OF HUMAN LIVER 5BETA-REDUCTASE (AKR1D1) IN COMPLEX WITH NADP AND CORTISONE. RESOLUTION 1.90 A. |
| 3COT | A:; B: | CRYSTAL STRUCTURE OF HUMAN LIVER DELTA(4)-3-KETOSTEROID 5BETA-REDUCTASE (AKR1D1) IN COMPLEX WITH PROGESTERONE AND NADP. RESOLUTION: 2.03 A. |
| 3DOP | A:; B: | CRYSTAL STRUCTURE OF 5BETA-REDUCTASE (AKR1D1) IN COMPLEX WITH NADP+ AND 5BETA-DIHYDROTESTOSTERONE, RESOLUTION 2.00A |
| 3G1R | A:; B: | CRYSTAL STRUCTURE OF HUMAN LIVER 5BETA-REDUCTASE (AKR1D1) IN COMPLEX WITH NADP AND FINASTERIDE. RESOLUTION 1.70 A |
| 3GUG | A: | CRYSTAL STRUCTURE OF AKR1C1 L308V MUTANT IN COMPLEX WITH NADP AND 3,5-DICHLOROSALICYLIC ACID |
| 3NTY | A: | CRYSTAL STRUCTURE OF AKR1C1 IN COMPLEX WITH NADP AND 5-PHENYL,3-CHLOROSALICYLIC ACID |
| 3U2C | A: | ALDOSE REDUCTASE IN COMPLEX WITH NSAID-TYPE INHIBITOR AT 1.0 A RESOLUTION |
| 3UZW | A:; B: | CRYSTAL STRUCTURE OF 5BETA-REDUCTASE (AKR1D1) E120H MUTANT IN COMPLEX WITH NADP+ |
| 3UZX | A:; B: | CRYSTAL STRUCTURE OF 5BETA-REDUCTASE (AKR1D1) E120H MUTANT IN COMPLEX WITH NADP+ AND EPIANDROSTERONE |
| 3UZY | A:; B: | CRYSTAL STRUCTURE OF 5BETA-REDUCTASE (AKR1D1) E120H MUTANT IN COMPLEX WITH NADP+ AND 5BETA-DIHYDROTESTOSTERONE |
| 3UZZ | A:; B: | CRYSTAL STRUCTURE OF 5BETA-REDUCTASE (AKR1D1) E120H MUTANT IN COMPLEX WITH NADP+ AND DELTA4-ANDROSTENEDIONE |
| 4GA8 | A: | HUMAN AKR1B10 MUTANT V301L COMPLEXED WITH NADP+ AND SORBINIL |
| 4GAB | A: | HUMAN AKR1B10 MUTANT V301L COMPLEXED WITH NADP+ AND FIDARESTAT |
| 4ICC | X: | CRYSTAL STRUCTURE OF HUMAN AKR1B10 COMPLEXED WITH NADP+ AND JF0064 |
| 4JIH | A: | CRYSTAL STRUCTURE OF AKR1B10 COMPLEXED WITH NADP+ AND EPALRESTAT |
| 4JII | X: | CRYSTAL STRUCTURE OF AKR1B10 COMPLEXED WITH NADP+ AND ZOPOLRESTAT |
)
)